Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
Étude 115521 : étude de phase 1-2, d’escalade de dose, évaluant la tolérance et l’efficacité, du GSK525762, un inhibiteur de BET, chez des patients ayant un carcinome de la ligne médiane NUT et d’autres cancers. https://kusajili.com:443/Trial/u0cZQEWoT0yMSncMFsPvtQ%24etude-115521-etude-de-phase-1-2-descalade-de-dose-evaluant-la-tolerance-et-lefficacite-du-gsk525762-un-inhibiteur-de-bet-chez-d
I have read and accept the terms of use of the site and the Privacy Policy
Send your message